NCT02447965

Brief Summary

The purpose of this study is to show that the use of preoperative rectus sheath blocks can ultimately alleviate the need for using nondepolarizing muscle relaxants during certain abdominal procedures.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 19, 2015

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

July 21, 2017

Status Verified

July 1, 2017

Enrollment Period

11 months

First QC Date

May 11, 2015

Last Update Submit

July 19, 2017

Conditions

Keywords

Rectus Sheath BlocksAbdominal Surgery

Outcome Measures

Primary Outcomes (1)

  • Total consumption of nondepolarizing muscle relaxants used during abdominal surgery.

    The duration of study therapy is only for the perioperative preparation period (usually 4-5 hrs) for the subject's abdominal procedure

Study Arms (2)

Bupivacaine

ACTIVE COMPARATOR

Will have 20ml of bupivacaine injected into each rectus sheath.

Drug: Bupivacaine

Normal Saline

PLACEBO COMPARATOR

Will have 20ml of normal saline injected into each rectus sheath.

Drug: Normal Saline

Interventions

Using ultrasound guidance bupivacaine will be injected into the active group's rectus abdominis sheath.

Also known as: Marcaine
Bupivacaine

Using ultrasound guidance normal saline will be injected into the placebo group's rectus abdominis sheath.

Normal Saline

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled to undergo an abdominal procedure with a periumbilical or midline incision above the umbilicus
  • Age ≥ 18 years.
  • American Society of Anesthesiologists physical status class 1 to 3

You may not qualify if:

  • Known coagulopathy
  • Preexisting muscular disease
  • Medical conditions contraindicated to bupivacaine, succinylcholine or other medication used in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univerisity of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

Location

Related Publications (3)

  • Kimura F, Oishi M, Yakoshi C, Ogasawara C, Ishihara H, Hirota K. [Rectus sheath block and transversus abdominis plane block for a patient with Lambert-Eaton myasthenic syndrome undergoing low anterior resection]. Masui. 2013 Aug;62(8):989-91. Japanese.

    PMID: 23984583BACKGROUND
  • Quek KH, Phua DS. Bilateral rectus sheath blocks as the single anaesthetic technique for an open infraumbilical hernia repair. Singapore Med J. 2014 Mar;55(3):e39-41. doi: 10.11622/smedj.2014042.

    PMID: 24664392BACKGROUND
  • Bashandy GM, Elkholy AH. Reducing postoperative opioid consumption by adding an ultrasound-guided rectus sheath block to multimodal analgesia for abdominal cancer surgery with midline incision. Anesth Pain Med. 2014 Aug 10;4(3):e18263. doi: 10.5812/aapm.18263. eCollection 2014 Aug.

    PMID: 25289373BACKGROUND

MeSH Terms

Conditions

HerniaPain, Postoperative

Interventions

BupivacaineSaline Solution

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Andrew G Cain, M.D.

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2015

First Posted

May 19, 2015

Study Start

January 1, 2016

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

July 21, 2017

Record last verified: 2017-07

Locations